The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study

References

• Aceijas , C. , Oppenheimer , E. , Stimson , G.V. , Ashcroft , R.E. , Matic , S. and Hickman , M. 2006 . Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the “Treating 3 million by 2005. Making it happen. The WHO strategy” (“3 by 5”) . Addiction , 101 : 1246 – 1253 .
   PubMed Web of Science ®Google Scholar
• Altice , F.L. and Friedland , G.H. 1998 . The era of adherence to HIV therapy . Annals of Internal Medicine , 129 : 503 – 505 .
   PubMed Web of Science ®Google Scholar
• Altice , F.L. , Mostashari , F. and Friedland , G.H. 2001 . Trust and the acceptance of and adherence to antiretroviral therapy . Journal of Acquired Immune Deficiency Syndrome , 28 : 47 – 58 .
   PubMed Web of Science ®Google Scholar
• Beattie , K. 2005 . Adult correctional service in Canada, 2003–2004 , Ottawa , ON : Statistics Canada .
   Google Scholar
• Bouhnik , A.D. , Chesney , M. , Carrieri , P. , Gallais , H. , Moreau , J. Moatti , J.P. 2002 . Nonadherence among HIV-infected injecting drug users: The impact of social instability . Journal of Acquired Immune Deficiency Syndrome , 31 ( Suppl. 3 ) : S149 – S153 .
   PubMed Web of Science ®Google Scholar
• British Columbia Corrections . 2006 . The strategic plan of B. C. corrections: A commitment to public safety 2006–2009 . Victoria , BC : Ministry of public safety and Solicitor General .
   Google Scholar
• Demas , P. , Schoenbaum , E. , Hirky , A.E. , Wills , T.A. , Doll , L.S. Hartel , D.M. 1998 . The relationship of HIV treatment acceptance and adherence to psychological factors among injection drug users . AIDS and Behavior , 2 : 283 – 292 .
   Google Scholar
• Ferrando , S.J. , Wall , T.L. , Batki , S.L. and Sorensen , J.L. 1996 . Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease . American Journal of Drug & Alcohol Abuse , 22 : 475 – 487 .
   PubMed Web of Science ®Google Scholar
• Hammer , S.M. , Squires , K.E. , Hughes , M.D. , Grimes , J.M. , Demeter , L.M. Currier , J.S. 1997 . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS clinical trials group 320 study team . New England Journal of Medicine , 337 : 725 – 733 .
   PubMed Web of Science ®Google Scholar
• Hogg , R. , Yip , B. , Kully , C. , Craib , K. , O'Shaughnessy , M. Schechter , M. 1999 . Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens . Canadian Medical Association Journal , 160 ( 5 ) : 659 – 665 .
   PubMed Web of Science ®Google Scholar
• Kerr , T. , Marshall , A. , Walsh , J. , Palepu , A. , Tyndall , M. Montaner , J. 2005 . Determinants of highly active antiretroviral therapy discontinuation among injection drug users . AIDS Care , 17 : 539 – 549 .
   PubMed Web of Science ®Google Scholar
• Klitzman , R.L. , Kirshenbaum , S.B. , Dodge , B. , Remien , R.H. , Ehrhardt , A.A. Johnson , M.O. 2004 . Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study . AIDS Care , 16 : 628 – 640 .
   PubMed Web of Science ®Google Scholar
• Muma , R.D. , Ross , M.W. , Parcel , G.S. and Pollard , R.B. 1995 . Zidovudine adherence among individuals with HIV infection . AIDS Care , 7 : 439 – 447 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M.W. , Chan , K. , Wood , E. , Montaner , J.S. and Hogg , R.S. 2004 . Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes . Antiviral Therapy , 9 : 713 – 719 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M.W. , Li , K. , Yip , B. , O'Shaughnessy , M.V. Schechter , M.T. 2003 . Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy . Journal of Urban Health , 80 ( 4 ) : 667 – 675 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M.W. , Li , K. , Yip , B. , Hogg , R.S. O'Shaughnessy , M.V. 2001 . Access and sustainability of antiretroviral therapy among injection drug users in Vancouver . Canadian Journal of Infectious Diseases , 12 ( Suppl. B ) : 32B
   Google Scholar
• Pontali , E. 2005 . Antiretroviral treatment in correctional facilities . HIV Clinical Trials , 6 : 25 – 37 .
   PubMed Web of Science ®Google Scholar
• Porter , K. , Babiker , A. , Bhaskaran , K. , Darbyshire , J. , Pezzotti , P. and Walker , A.S. 2003 . Determinants of survival following HIV-1 seroconversion after the introduction of HAART . Lancet , 362 : 1267 – 1274 .
   PubMed Web of Science ®Google Scholar
• Rothon , D. , Mathias , R. and Schechter , M.T. 1994 . Prevalence of HIV infection in provincial prisons in British Columbia . Canadian Medical Association Journal , 151 : 781 – 787 .
   PubMed Web of Science ®Google Scholar
• Singh , N. , Squier , C. , Sivek , C. , Wagener , M. , Nguyen , M.H. and Yu , V.L. 1996 . Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance . AIDS Care , 8 : 261 – 269 .
   PubMed Web of Science ®Google Scholar
• Small , W. , Kain , S. , Laliberte , N. , Schechter , M. , O'Shaughnessy , M. and Spittal , P. 2005 . Incarceration, addiction, and harm reduction: Inmates’ experience injecting drugs in prison . Substance Use and Misuse , 40 : 831 – 843 .
   PubMed Web of Science ®Google Scholar
• Springer , S.A. , Pesanti , E. , Hodges , J. , Macura , J. , Doros , G. and Altice , F.L. 2004 . Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community . Clinical Infectious Diseases , 38 : 1754 – 1760 .
   PubMed Web of Science ®Google Scholar
• Statistics Canada . 1999 . A one-day snapshot of inmates in Canada's adult correctional facilities . Ottawa , ON : Canadian Centre for Justice Statistics .
   Google Scholar
• Statistics Canada . 2000 . Adult criminal court data tables 1998/99 . Ottawa , ON : Canadian Centre for Justice Statistics .
   Google Scholar
• Strathdee , S.A. , Palepu , A. , Cornelisse , P.G. , Yip , B. , O'Shaughnessy , M.V. Montaner , J.S. 1998 . Barriers to use of free antiretroviral therapy in injection drug users . JAMA , 280 : 547 – 549 .
   PubMed Web of Science ®Google Scholar
• Vervoort , S.C. , Borleffs , J.C. , Hoepelman , A.I. and Grypdonck , M.H. 2007 . Adherence in antiretroviral therapy: A review of qualitative studies . AIDS , 21 : 271 – 281 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Kerr , T. and Montaner , J.S. 2007 . HIV treatment, injection drug use, and illicit drug policies . Lancet , 370 : 8 – 10 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Tyndall , M.W. , Schechter , M.T. , O'Shaughnessy , M.V. and Hogg , R.S. 2003a . Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy . Journal of Infectious Diseases , 188 : 1164 – 1170 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Yip , B. , Tyndall , M.W. , Schechter , M.T. O'Shaughnessy , M.V. 2003b . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . Canadian Medical Association Journal , 169 : 656 – 661 .
   PubMed Web of Science ®Google Scholar